Filing Details
- Accession Number:
- 0001571049-15-001278
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-19 17:02:02
- Reporting Period:
- 2015-02-17
- Filing Date:
- 2015-02-19
- Accepted Time:
- 2015-02-19 17:02:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1601340 | G Thomas Dagger | 300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666-6712 | Svp, Gen Counsel And Corp Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2015-02-17 | 4,000 | $11.83 | 4,000 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2015-02-17 | 4,000 | $31.91 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Option to purchase Class A Common Stock | Disposition | 2015-02-17 | 4,000 | $0.00 | 4,000 | $11.83 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
18,100 | 2012-03-01 | 2019-02-28 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2014.
- Reflects the weighted average sale price of the Class A Common Stock sold. The shares were sold in multiple trades at prices ranging from $31.00 to $32.77 per share. The Reporting Person will provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.